Abstract
Editorial: Cell-Based Therapies for Diabetic Microvascular Complications.
Highlights
There is an alarming increase in the number of cases of diabetes with the global prevalence rate at 9% for the year 2014 [1]
Diabetes is strongly associated with microvascular complications and with the rise in the numbers of people with diabetes, there is a precipitous increase in patients suffering from diabetic microvascular complications [4, 5]
This novel therapeutic strategy involves stem cells obtained from a variety of sources, such as circulating endothelial progenitor cells, mesenchymal stromal cells (MSCs), embryonic stem cells, and inducible pluripotent stem cells
Summary
There is an alarming increase in the number of cases of diabetes with the global prevalence rate at 9% for the year 2014 [1]. This research topic discussed therapeutic potential and recent developments in cells therapies for the treatment of diabetic microvascular complications. Mesenchymal stromal cells are at a forefront of the cell-based therapies and Davey et al elegantly summarized importance of MSCs for diabetic microvascular complications [6].
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
